Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
8 closest matches · ranked by relevance
Toxic Shock Syndrome · Vaccination; Sepsis
Primary: Number of Participants With Adverse Events as a Measure of Safety and Tolerability — 1; 1; 2; 7 participants with any solicited AE
Toxic-Shock Syndrome · Sepsis
Primary: Number of Participants With Adverse Events as a Measure of Safety — 7; 1; 1; 0 participants
Toxic Shock Syndrome
Primary: Number of Participants (Percentage) With Abnormal Laboratory Values and/or Adverse Events That Are Related to Treatment — 9; 11; 11; 12 Participants
Vaginal Microflora
Primary: Percentage of Subjects Showing Unfavorable Changes in Primary Microflora — 52.7; 52.9; 60.0 Percentage of Participants
Nonmalignant Breast Conditions · Breast Cancer
Primary: Number of Subjects With Drain Bulb Fluid Bacterial Colonization at Approximately 1 Week — 10; 21 participants — p=0.02
Menstruation
Primary: Tolerance of Tampon Wear Via Physician Assessment of Vaginal Health — 0; 0; 0; 0 Participants
Vaginal Microbiota
Primary: Change in Relative Abundance of Lactobacillus Species — .0084; -.0014; -.00004; .0104 relative abundance
Prevention of Travelers' Diarrhea
Primary: Geometric Mean Titer (GMT) After First and Second Vaccination With LT Vaccine Patch and Comparison Against Placebo — 432.6; 400.5; 4477.5; 490.6 geometric mean titer